Journal of Clinical Oncology, Vol 22, No 16 (August 15), 2004: pp. 3420-3428
© 2004 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2004.02.019
Role of the Dependence Receptor DCC in Colorectal Cancer Pathogenesis
Patrick Mehlen,
Eric R. Fearon
From the Apoptosis/Differentiation Laboratory, Equipe labelisée La Ligue Molecular and Cellular Genetic Center, University of Lyon, Villeurbanne; International Agency For Research in Cancer, Lyon, France; and Division of Molecular Medicine & Genetics, University of Michigan Medical Center, Ann Arbor, MI
Address reprint requests to P. Mehlen, MD, Apoptosis/Differentiation LaboratoryMolecular and Cellular Genetic Center, CNRS UMR 5534, University of Lyon, 69622 Villeurbanne, France; e-mail: mehlen{at}univ-lyon1.fr
More than a decade ago, the DCC (deleted in colorectal cancer) gene was proposed as a putative tumor suppressor gene. Data supporting this proposal included observations that one DCC allele was deleted in roughly 70% of colorectal cancers, some cancers had somatic mutations of the DCC gene, and DCC expression was often reduced or absent in colorectal cancer tissues and cell lines. Despite subsequent studies which have supported DCC's potential role as a tumor suppressor gene, the rarity of point mutations identified in DCC coding sequences, the lack of a tumor predisposition phenotype in mice heterozygous for DCC inactivating mutations, and the presence of other known and candidate tumor suppressor genes on chromosome 18q have raised questions about DCC's candidacy. Following its initial characterization, the DCC protein was identified as a transmembrane receptor for netrins, key factors in axon guidance in the developing nervous system. At first glance, the established role of DCC and netrin-1 during organization of the spinal cord could be viewed as a further challenge to the position that DCC inactivation might play a significant role in tumorigenesis. However, recent observations on DCC's functions in intracellular signaling have renewed interest in the potential contribution of DCC inactivation to cancer. In particular, data indicate that, when engaged by netrin ligands, DCC may activate downstream signaling pathways. Moreover, in settings where netrin is absent or at low levels, DCC can promote apoptosis. Here, we review DCC's candidacy as a tumor suppressor gene, with an emphasis on how recent molecular analyses of DCC have offered support for the notion that DCC may function as a tumor suppressor gene.
Authors' disclosures of potential conflicts of interest are found at the end of this article.
This article has been cited by other articles:

|
 |

|
 |
 
D. Goldschneider, N. Rama, C. Guix, and P. Mehlen
The Neogenin Intracellular Domain Regulates Gene Transcription via Nuclear Translocation
Mol. Cell. Biol.,
June 15, 2008;
28(12):
4068 - 4079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Fitamant, C. Guenebeaud, M.-M. Coissieux, C. Guix, I. Treilleux, J.-Y. Scoazec, T. Bachelot, A. Bernet, and P. Mehlen
Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer
PNAS,
March 25, 2008;
105(12):
4850 - 4855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Carvalho, A. Chuang, W.-W. Jiang, J. Lee, S. Begum, L. Poeta, M. Zhao, C. Jeronimo, R. Henrique, C. S. Nayak, et al.
Deleted in Colorectal Cancer Is a Putative Conditional Tumor-Suppressor Gene Inactivated by Promoter Hypermethylation in Head and Neck Squamous Cell Carcinoma
Cancer Res.,
October 1, 2006;
66(19):
9401 - 9407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Raz, B. He, R. Rosell, and D. M. Jablons
Current concepts in bronchioloalveolar carcinoma biology.
Clin. Cancer Res.,
June 15, 2006;
12(12):
3698 - 3704.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Furne, V. Corset, Z. Herincs, N. Cahuzac, A.-O. Hueber, and P. Mehlen
The dependence receptor DCC requires lipid raft localization for cell death signaling.
PNAS,
March 14, 2006;
103(11):
4128 - 4133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Li, J. Aurandt, C. Jurgensen, Y. Rao, and K.-L. Guan
FAK and Src kinases are required for netrin-induced tyrosine phosphorylation of UNC5
J. Cell Sci.,
January 1, 2006;
119(1):
47 - 55.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Herincs, V. Corset, N. Cahuzac, C. Furne, V. Castellani, A.-O. Hueber, and P. Mehlen
DCC association with lipid rafts is required for netrin-1-mediated axon guidance
J. Cell Sci.,
April 15, 2005;
118(8):
1687 - 1692.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|